New Men B immunisation advice

Following recent high profile stories about child deaths from meningitis B, Public Health England has issued further advice:

Men B immunisation programme

Following recent media coverage about the death of a young girl from invasive meningococcal disease caused by Men B, many GP practices have had queries from parents about the availability of Men B immunisation. 

This information is taken from Public Health England publications and the GOV.UK website (see below for details).

What is the national policy for Men B immunisation?

The Men B immunisation programme started on 1 September 2015 for babies aged 2 months, ie, babies born on or after 1 July 2015.  There was a limited catch-up programme for babies born on or after 1 May 2015.  The routine schedule is for immunisation to be given at 2 and 4 months with the primaries, with a booster at 12 months.

Can I vaccinate children born before 1 May 2015 if parents request it? 

No. The national stock of Bexsero® should only be used to vaccinate children who are eligible for NHS vaccination.

Can I vaccinate children born on or after 1 May 2015 who have not yet been vaccinated?

Yes.  All children in the eligible cohort (ie, born on or after 1 May 2015) remain eligible for Men B immunisation until the age of two years. When Bexsero® has not been given as part of a primary course, give two doses at least two months apart. Those children who have received one dose before their first birthday only require one more dose. Please see the MenB PGD for more information.

If parents ask to pay for Men B immunisation for their children, what should I tell them?

GPs should not charge their own patients (ie, those registered at their practice) a private fee for the vaccine.

Parents seeking the vaccine privately should be made aware that they will be liable for the full costs of the vaccine and any additional administration charges that the private provider may apply. We understand that GSK has supply constraints on the Bexsero vaccine for the private market. Practices must not use centrally-procured stock for the national programme to vaccinate private patients or any patients outside the eligible cohort (other than those at high risk as defined in the green book).

Further information

Last updated : 16 Mar 2016

 

Board update - April 2019 (15 Apr 2019)

Several key decisions affecting members were taken at the Londonwide LMCs Board of Directors meeting in March. These included:  Increasing the hourly honoraria rate for LMC activity by £3...
Read more »

Sessional GP subcommittee election nominations (15 Apr 2019)

Nominations for all sixteen seats of the Sessional GP subcommittee for the 2019-22 session are open until 12pm Thursday 18 April 2019. To participate in the election, please log...
Read more »

Scrutiny of NHS spending and plans (12 Apr 2019)

Earlier this month the Parliamentary Public Accounts Committee published a critical report on NHS financial sustainability and the NHS Long Term Plan, following evidence from NHS England, NHS Improvement,...
Read more »

UK LMC Conference 2019 update (12 Apr 2019)

The UK LMC Conference was held in Belfast on 19-20 March. A full list of the motions proposed and carried can be found here. Motion 22 from Tower Hamlets...
Read more »

Feedback sought on legal changes proposed for NHS Long Term Plan delivery (20 Mar 2019)

NHS England are seeking changes to the Health and Social Care Act, including the competition rules affecting CCGs, who can sit on their boards and how closely they can work...
Read more »

First statutory National Data Guardian for Health and Social Care appointed (19 Mar 2019)

Dame Fiona Caldicott has been appointed as the first statutory National Data Guardian (NDG) for Health and Social Care. This remit of this role is to ensure that the public...
Read more »

New Daffodil Standards and QOF: Supporting quality improvements in palliative and end of life care (19 Mar 2019)

March is the awareness month for Marie Curie’s Daffodil campaign. Part of this campaign includes the Daffodil Standards for palliative and end of life care, aimed at GP practices, and...
Read more »
Next Page »
« Previous Page